North Carolina Department of Health and Human Services North Carolina Public Health
Division of Public Health (DPH) Site Navigation
Links open in new windows
Other Important NC Public Health Links
Links open in new windows
NC Publich Health Partnerships
Links open in new windows
Centers for Disease Control and Prevention Links
Links open in new windows

Get Adobe Reader to Access PDF files -- It's free
 

Virology / Serology - HIV

Three serologic assays are available for the detection of antibodies to the human immunodeficiency virus type1 (HIV –1). An enzyme immunoassay (EIA) is used as a screening test for antibodies to HIV-1. All reactive EIAs are repeated in duplicate to verify the initially reactive test result.  All repeatedly reactive EIA tests (two or more reactive) are tested by the Western blot (WB) assay.  In November 2002, the HIV/STD Prevention and care Branch and the State Laboratory of Public Health instituted new HIV testing protocols for the detection of acute HIV infection. All HIV specimens continue to be tested by EIA methodology for HIV antibodies.  In addition, all negative HIV specimens are then tested for HIV RNA using molecular methodology to detect acute HIV infections. At least 3mL of serum is required for the new HIV testing protocol.

Specimen Acceptance Policy

Specimens are accepted from the following:

Only serum samples are acceptable for HIV testing on a routine basis. Specimens submitted to the Virology/Serology Branch must be accompanied by a fully completed scannable submission form. Failure to supply the requested information may result in significantly delayed specimen testing. Improperly submitted specimens will be stored for seven days pending verbal and/or written notification of the submitter. Unless alternate arrangements are initiated by the submitter upon notification of specimen rejection, the specimen will be discarded at the end of the holding period.

Specimen Collection

A minimum of 2 mL of serum should be submitted for HIV testing. Aseptically collect whole blood in a red top tube or in a serum separator tube. Let specimen stand 30 minutes to ensure complete clotting of the blood. Centrifuge for 5-10 minutes at 1,000-1,500 xg. Transfer serum to a well constructed plastic screw capped vial with threads on the outside. Excessively hemolyzed or extremely lipemic sera are unacceptable for HIV assays. Specimens that are not acceptable for testing will be reported UNSATISFACTORY.

Label each vial of serum with the patient identifying number located on the lower section of Part C on the scannable HIV form. Complete the HIV submission form in its entirety. All items on this form must be completed before the specimen can be processed.

Specimen Shipping

Scannable forms should be placed inside an envelope with cardboard to ensure that the form arrives at the lab without folds, tears or wrinkles and the return address and collection date should be recorded on the envelope in the marked space in the upper left-hand corner. Specimens should be placed inside a plastic bag and then placed into the mailer marked "CTS Serology" and the return address and date of collection entered on the outside in the marked space. If Courier service is used, the appropriate barcode should be affixed to the front of the envelope and both the envelope with the scannable forms and the specimen mailer should then be placed inside a large plastic bag and sealed. Specimens for other laboratory services should not be placed in this bag. Specimens can be shipped at ambient temperatures.

Forms are available to Counseling and Testing Sites through the Virology/Serology Branch Office, telephone (919) 733-7544. Envelope mailers for forms, plastic screw-capped vials and color-coded mailers for specimens are available from the Laboratory Mailroom, PO Box 28047, Raleigh, North Carolina 27611-8047, telephone (919) 733-7656. Submitters of reference specimens for Western blot serology should use DHHS form #3445 and the "Special Serology" mailer available from the Laboratory Mailroom.

Specimen Reporting

The following chart provides information regarding turn-around-times and interpretations. A brief statement of the "normal" values for each assay is given under the heading "Negative Reference Range".

Testing Turn-around-time
Description Test Procedure Negative Reference Range Turn-Around-Time
Human Immunodeficiency virus type 1 antibody EIA-Qualitative No antibody detected 4 working days
Human Immunodeficiency virus type 1 antibody Western blot->Qualitative No antibody detected 5 working days

The State Laboratory of Public Health uses the APHL/CDC criteria shown below for the interpretation of the Western blot.

Interpretation of the Western blot
Interpretation Criteria
Negative The absence of any and all bands - not just viral bands
Indeterminate The presence of any other band or bands that fail to meet the positive criteria.
Positive The presence of any two of the following bands:
  • p24
  • gp41
  • gp120/gp160
Reference: Centers for Disease Control. Interpretation and Use of the Western Blot Assay for Serodiagnosis of Human Immunodeficiency Virus Type 1 Infections. MMWR 1989; 38:1-7.

The following recommendations are made regarding follow-up specimens:

Relevant Links:

See also:

Last Modified: October 14, 2008 11:42 AM